Research Studies
Research Activities at the Layton Aging and Alzheimer's Disease Center are organized into various categories:
Clinical Trials and Intervention Studies currently recruiting Participants
Alzheimer's Disease Studies
Alzheimer's Disease Clinical Core
Randomized, Double-Blind, Placebo-Controlled, Two Dose-Arm, Parallel Study of the Safety and Effectiveness of Immune Globulin Intravenous (Human), 10% (IGIV, 10%) for the Treatment of Mild-to-Moderate Alzheimer's Disease
MRI of the Aging Brain
Augmentative and Alternative Communication (AAC) for Dementia and Progressive Aphasia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients with Prodromal Alzheimer’s Disease
Alzheimer’s Disease Neuroimaging Initiative Grand Opportunity (ADNI-GO)
Lipoic Acid and omega-3 fatty acids in Alzheimer’s disease
Caregiver Studies
Meditation or education for Alzheimer caregivers: stress and physiology (aka The Alzheimer's Caregiver study)
Long Term Longitudinal Community Studies
These studies provide a clinical assessment of a patient over a long period of time in order to investigate disease course and risk factors.
OBAS - Oregon Brain Aging Study focuses on identifying factors that protect individuals from developing dementia in later life and promote a maximal cognitive health span.
CBDP - Community Brain Donor Program
AADAPt - The African American Dementia and Aging Project is a longitudinal study of brain aging in elderly African Americans in Northeast Portland.
KEAP - Klamath Exceptional Aging project is a community based study that follows longitudinally, rural residing persons 85 or older in the Klamath basin of Oregon.
ISAAC – Intelligent Systems for Assessment of Aging Changes Study
